WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and HanchorBio Inc., a global clinical-stage biotechnology company advancing next-generation ...
Leading our In Focus on next-generation antibody therapeutics, this video details the three key categories of this next generation: bi-specific antibodies, antibody–drug conjugates and nanobodies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results